Welcome to Stanton Glantz blog
Commentary on tobacco, cannabis and public health
Latest from the Blog
FDA should not authorize marketing flavored ZYN nicotine pouches as modified risk products because Swedish Match failed to provide evidence specific to ZYN demonstrating that they will benefit the health of the population, including youth
My colleagues at UCSF and Stanford have submitted this public comment to FDA opposing its approval of Swedish Match (owned by Philip Morris International) claim that ZYN is less dangerous (PDF). The TPSAC tracking number is mk4-k6rg-rvku and the general docket tracking number is mk5-q1p5-yauh on Regulations.gov. Here is the comment: FDA’s should not authorize…
HTP attract youth, act as a gateway to cigarettes, and keep adults smoking
The cigarette companies have introduced several generations of heated tobacco products (HTP) going back to the 1960s in the hope that generating the nicotine aerosol the consumer inhales by heating rather than burning the tobacco would lower risk by avoiding the toxic combustion products created by burning tobacco. None of these earlier products were successful…
New paper by Hajek group presents misleading incomplete results about dual use when using e-cigs as cessation aid
One concern about giving smokers e-cigarettes as a smoking cessation aid is that doing so instantly converts them into dual users (smoking both cigarettes and e-cigarettes), which adds the risks of e-cigarette use to cigarette use. Peter Hajek’s group just published Patterns of e-Cigarette Use and Smoking Cessation Outcomes: Secondary Analysis of a Large Randomised…
Get new content delivered directly to your inbox.
Stanton Glantz blog 